Light Mode
$4.66 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.66, $0.13 below the day’s high of $4.79
+3.22 (+223.61%) / 6M
Momentum, market sentiment, and recent alerts
OABI reads neutral: price sits above one of the two key moving averages, the 12-month move is +193.1%.
No alerts for OABI in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
OmniAb, Inc. operates as a drug discovery company. The firm focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.